{"id":557075,"date":"2021-08-10T19:58:01","date_gmt":"2021-08-10T19:58:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=557075"},"modified":"2021-08-10T19:58:01","modified_gmt":"2021-08-10T19:58:01","slug":"regenerative-medicine-market-worth-179-billion-by-2025-major-players-are-3m-us-allergan-plc-ireland-amgen-inc-us","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/regenerative-medicine-market-worth-179-billion-by-2025-major-players-are-3m-us-allergan-plc-ireland-amgen-inc-us_557075.html","title":{"rendered":"Regenerative Medicine Market worth $17.9 billion by 2025 | Major Players are 3M (US), Allergan plc (Ireland), Amgen, Inc. (US)"},"content":{"rendered":"
\n
\"Regenerative<\/a><\/div>\n
\n
3M (US), Allergan plc (Ireland), Amgen, Inc. (US), Aspect Biosystems (Canada), bluebird bio (US), Kite Pharma (US), Integra LifeSciences Holdings Corporation (US), MEDIPOST Co., Ltd. (South Korea), Medtronic plc (Ireland), Anterogen Co., Ltd. (South Korea), MiMedx Group (US) are kwy players in regenerative medicine market.<\/div>\n<\/div>\n<\/div>\n
Regenerative Medicine Market Research Report Gives in Detailed Analysis of Industry Segments, Opportunities, Growth and Size That Will Help Your Business Grow.<\/div>\n

According to the new market research report “<\/strong>Regenerative Medicine Market<\/a> by Product (Cell Therapies (Autologous, Allogenic), Stemcell Therapy, Tissue-engineering, Gene Therapy), Application (Wound Care, Musculoskeletal, Oncology, Dental, Ocular), Geography – Global Forecast to 2025″,<\/strong> published by MarketsandMarkets™, the market is projected to reach USD 17.9 billion<\/span> by 2025 from USD 8.5 billion<\/span> in 2020, at a CAGR of 15.9%. Growth in this market is largely driven by the rising prevalence of chronic diseases, genetic disorders, and cancer; rising investments in regenerative medicine research; and the growing pipeline of regenerative medicine products.<\/p>\n

Browse and in-depth TOC on <\/em>“Regenerative Medicine Market”
131 – Tables
38 – Figures
165 – Pages<\/strong><\/p>\n

Download PDF Brochure: <\/strong>https:\/\/www.marketsandmarkets.com\/pdfdownloadNew.asp?id=65442579<\/a><\/p>\n

The tissue-engineered products segment accounted for the largest share of the Regenerative Medicine Market, by product segment, in 2019<\/strong><\/p>\n

Based on products, the market is segmented into tissue-engineered products, cell therapies, gene therapies, and progenitor and stem cell therapies. The tissue-engineered products segment accounted for the largest share in the market in 2019. The increasing adoption of tissue-engineered products for the treatment of chronic wounds and musculoskeletal disorders and the rising funding for the R&D of regenerative medicine products and therapies are the major factors driving the growth of this segment.<\/p>\n

Oncology segment to register the highest growth rate during the forecast period<\/strong><\/p>\n

Based on applications, the Regenerative Medicine Market is segmented into musculoskeletal disorders, wound care, oncology, ocular disorders, dental, and other applications. In 2019, the oncology segment accounted for the highest growth rate. This can be attributed to the rising prevalence of orthopedic diseases, growing geriatric population, increasing number of stem cell research projects, growing number of clinical researches\/trials, and the rich pipeline of stem cell products for the treatment of musculoskeletal disorders.<\/p>\n

Request Sample Pages: <\/strong>https:\/\/www.marketsandmarkets.com\/requestsampleNew.asp?id=65442579<\/a>

North America<\/span> is the largest regional market for Regenerative Medicine Market<\/strong><\/p>\n

The market is segmented into four major regions, namely, North America<\/span>, Europe<\/span>, Asia Pacific<\/span>, and the Rest of the World (RoW). In 2019, North America<\/span> accounted for the largest share in the market. The growth in the North American market can be attributed to rising stem cell banking, tissue engineering, and drug discovery in the region; expansion of the healthcare sector; and the high adoption of stem cell therapy and cell immunotherapies for the treatment of cancer and chronic diseases.<\/p>\n

The major players operating in this Regenerative Medicine Market<\/strong> are 3M<\/span> (US), Allergan plc (Ireland<\/span>), Amgen, Inc. (US), Aspect Biosystems (Canada<\/span>), bluebird bio (US), Kite Pharma (US), Integra LifeSciences Holdings Corporation (US), MEDIPOST Co., Ltd. (South Korea<\/span>), Medtronic plc (Ireland<\/span>), Anterogen Co., Ltd. (South Korea<\/span>), MiMedx Group (US), Misonix (US), Novartis AG (Switzerland<\/span>), Organogenesis Inc. (US), Orthocell Limited (Australia<\/span>), Corestem, Inc. (South Korea<\/span>), Spark Therapeutics (US), APAC Biotech (India<\/span>), Shenzhen Sibiono GeneTech Co., Ltd. (China<\/span>), Smith & Nephew plc (UK), Stryker Corporation (US), Takeda Pharmaceutical Company Limited (Japan<\/span>), Tego Science (South Korea<\/span>), Vericel Corporation (US), and Zimmer Biomet (US).<\/p>\n

Media Contact<\/span>
Company Name:<\/strong> MarketsandMarkets<\/a>
Contact Person:<\/strong> Mr. Aashish Mehra
Email:<\/strong> Send Email<\/a>
Phone:<\/strong> 18886006441
Address:<\/strong>630 Dundee Road Suite 430
City:<\/strong> Northbrook
State:<\/strong> IL 60062
Country:<\/strong> United States
Website:<\/strong> https:\/\/www.marketsandmarkets.com\/Market-Reports\/regenerative-medicine-market-65442579.html<\/a><\/p>\n

<\/object>\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

3M (US), Allergan plc (Ireland), Amgen, Inc. (US), Aspect Biosystems (Canada), bluebird bio (US), Kite Pharma (US), Integra LifeSciences Holdings Corporation (US), MEDIPOST Co., Ltd. (South Korea), Medtronic plc (Ireland), Anterogen Co., Ltd. (South Korea), MiMedx Group (US) are kwy … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401,405,406,403,404],"tags":[],"class_list":["post-557075","post","type-post","status-publish","format-standard","hentry","category-Business","category-Health-Medicine","category-Pharmaceuticals-Biotech","category-UK","category-US"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/557075","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=557075"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/557075\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=557075"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=557075"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=557075"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}